Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma

Aim. To study prognostic implications of a focal mature cell lesion of the bone marrow (BM) in patients with diffuse large В cell lymphosarcoma (DBLCL). Material and methods. 54 patients with histologically confirmed DBLCL were given first-line CHOP and CHOP-like courses from 1996 to 2003. B-cell na...

Full description

Bibliographic Details
Main Authors: A U Magomedova, A M Kremenetskaya, I A Vorobyev, S K Kravchenko, I В Kaplanskaya, R S Samoilova, E G Gemdzhyan, A I Vorobyev
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2004-07-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/29997
id doaj-fd9c0c1e112545c7a0b6b5b58b505b79
record_format Article
spelling doaj-fd9c0c1e112545c7a0b6b5b58b505b792020-11-25T02:58:05Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422004-07-01797606327025Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcomaA U MagomedovaA M KremenetskayaI A VorobyevS K KravchenkoI В KaplanskayaR S SamoilovaE G GemdzhyanA I VorobyevAim. To study prognostic implications of a focal mature cell lesion of the bone marrow (BM) in patients with diffuse large В cell lymphosarcoma (DBLCL). Material and methods. 54 patients with histologically confirmed DBLCL were given first-line CHOP and CHOP-like courses from 1996 to 2003. B-cell nature of the tumor was confirmed immunohistochemically, immunophenotypically and with flow fluorimetry. Results. In debute of the disease 16 patients had local involvement of the lymph organs (stage I-II by Enn-Arbor), 21 patients - generalized disease (stage III-IV) and 17 patients - involvement of nonlymphatic organs. Overall 3-year survival in first-line therapy in mature cell lesion of BM was 23%, without it - 0%. One-year event-free survival was 34 and 0%, respectively. Conclusion. The presence of a focal mature cell lesion of BM in DBLCL patients influences the prognosis. Regarding high frequency of transformation of mature cell lymphoproliferative diseases in DBLCL . focal lesion of BM is an indirect sign of a secondary nature of the disease.https://ter-arkhiv.ru/0040-3660/article/view/29997chopmature cell lesion of the bone marrowchopsurvival
collection DOAJ
language Russian
format Article
sources DOAJ
author A U Magomedova
A M Kremenetskaya
I A Vorobyev
S K Kravchenko
I В Kaplanskaya
R S Samoilova
E G Gemdzhyan
A I Vorobyev
spellingShingle A U Magomedova
A M Kremenetskaya
I A Vorobyev
S K Kravchenko
I В Kaplanskaya
R S Samoilova
E G Gemdzhyan
A I Vorobyev
Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma
Терапевтический архив
chop
mature cell lesion of the bone marrow
chop
survival
author_facet A U Magomedova
A M Kremenetskaya
I A Vorobyev
S K Kravchenko
I В Kaplanskaya
R S Samoilova
E G Gemdzhyan
A I Vorobyev
author_sort A U Magomedova
title Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma
title_short Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma
title_full Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma
title_fullStr Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma
title_full_unstemmed Prognostic implication of a focal lesion of bone marrow in diffuse large В cell lymphosarcoma
title_sort prognostic implication of a focal lesion of bone marrow in diffuse large в cell lymphosarcoma
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2004-07-01
description Aim. To study prognostic implications of a focal mature cell lesion of the bone marrow (BM) in patients with diffuse large В cell lymphosarcoma (DBLCL). Material and methods. 54 patients with histologically confirmed DBLCL were given first-line CHOP and CHOP-like courses from 1996 to 2003. B-cell nature of the tumor was confirmed immunohistochemically, immunophenotypically and with flow fluorimetry. Results. In debute of the disease 16 patients had local involvement of the lymph organs (stage I-II by Enn-Arbor), 21 patients - generalized disease (stage III-IV) and 17 patients - involvement of nonlymphatic organs. Overall 3-year survival in first-line therapy in mature cell lesion of BM was 23%, without it - 0%. One-year event-free survival was 34 and 0%, respectively. Conclusion. The presence of a focal mature cell lesion of BM in DBLCL patients influences the prognosis. Regarding high frequency of transformation of mature cell lymphoproliferative diseases in DBLCL . focal lesion of BM is an indirect sign of a secondary nature of the disease.
topic chop
mature cell lesion of the bone marrow
chop
survival
url https://ter-arkhiv.ru/0040-3660/article/view/29997
work_keys_str_mv AT aumagomedova prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT amkremenetskaya prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT iavorobyev prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT skkravchenko prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT ivkaplanskaya prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT rssamoilova prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT eggemdzhyan prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
AT aivorobyev prognosticimplicationofafocallesionofbonemarrowindiffuselargevcelllymphosarcoma
_version_ 1724708526845067264